DNDi will lead Phase II and III clinical development, with the first Phase II study scheduled to start in early 2021 in Indiafrom Moneycontrol Business News https://ift.tt/3a2DajB
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment